SonALAsense Presents Data From Study in Patients With Pediatric Brain Tumor
SonALAsense Welcomes Dr. Ely Benaim as Chief Medical Officer and Executive Vice President of Development
SonALAsense Announces Completion of First Cohort in Phase 2 Study of SONALA-001 Sonodynamic Therapy for Recurrent Glioblastoma